Lista de obras - Donghee Kim - Dominio Público Uruguay

Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease

artículo científico publicado en 2017

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.

artículo científico publicado en 2017

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD

artículo científico publicado en 2018

Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution

artículo científico publicado en 2019

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis

artículo científico publicado en 2019

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States

scientific article published in PLoS ONE

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA

scientific article published on 01 September 2019

Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study

artículo científico publicado en 2017

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation

artículo científico publicado en 2018

Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

artículo científico publicado en 2019

Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

artículo científico publicado en 2018

Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease

artículo científico publicado en 2020

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

artículo científico publicado en 2017

Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea

artículo científico publicado en 2018

Correction: Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis

artículo científico publicado en 2016

Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States.

artículo científico publicado en 2017

Depression is associated with non-alcoholic fatty liver disease among adults in the United States

artículo científico publicado en 2019

Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality

scientific article published on 27 January 2020

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016

article

Economic burden and healthcare utilization in nonalcoholic fatty liver disease

article

Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease

artículo científico publicado en 2017

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States

artículo científico publicado en 2019

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD

artículo científico publicado en 2018

Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients

artículo científico publicado en 2018

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

scientific article published on 01 March 2020

Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups

artículo científico publicado en 2019

Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers

scientific article published on 21 May 2019

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association

scientific article published on 01 June 2019

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2020

Increasing changes in visceral adiposity is associated with higher risk for colorectal adenoma: multilevel analysis in a prospective cohort

scientific article published on 10 December 2020

Judicious Use of Lipid Lowering Agents in the Management of NAFLD

artículo científico publicado en 2018

Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis

artículo científico publicado en 2018

Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment

artículo científico publicado en 2018

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2018

Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity

artículo científico publicado en 2017

Non-obese fatty liver disease is associated with lacunar infarct.

artículo científico publicado en 2017

Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia

artículo científico publicado en 2020

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft

scientific article published on 28 July 2018

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity

artículo científico

Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm

scientific article published on 26 June 2019

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis ⬇️

artículo científico publicado el 27 de junio de 2013

Optimal timing for hepatitis C antiviral therapy in the peritransplant period?

artículo científico publicado en 2017

PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-related Mortality in the United States

scientific article published on 29 April 2020

Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease

artículo científico publicado en 2017

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary

scientific article published on 13 May 2019

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

artículo científico publicado en 2018

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation

scientific article published on 05 June 2019

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score.

artículo científico publicado en 2013

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease

article

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study

artículo científico publicado en 2019

Recent Epidemiology of Nonalcoholic Fatty Liver Disease

scientific article published on 15 September 2020

Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.

artículo científico publicado en 2018

Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease.

artículo científico publicado en 2017

Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease

artículo científico publicado en 2017

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease

artículo científico publicado en 2019

Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States

artículo científico publicado en 2019

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2019

The Role of Cannabinoids in the Setting of Cirrhosis

artículo científico publicado en 2018

The Role of Vitamin E in the Treatment of NAFLD

artículo científico publicado en 2018

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD

artículo científico publicado en 2019

The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States

artículo científico publicado en 2019

Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014

artículo científico publicado en 2020

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017

scientific article published on 25 June 2019

Trends in Mortality in Hepatitis C Infection and Alcoholic Liver Disease based on Drug Overdose in the United States

scientific article published on 04 November 2020

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014

scientific article published on 04 June 2019

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis

scientific article published on 12 December 2018

When to Initiate Weight Loss Medications in the NAFLD Population

artículo científico publicado en 2018

Lista de obras de Donghee Kim

Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD

Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA

Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation

Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea

Correction: Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis

Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States.

Depression is associated with non-alcoholic fatty liver disease among adults in the United States

Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016

Economic burden and healthcare utilization in nonalcoholic fatty liver disease

Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD

Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups

Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease

Increasing changes in visceral adiposity is associated with higher risk for colorectal adenoma: multilevel analysis in a prospective cohort

Judicious Use of Lipid Lowering Agents in the Management of NAFLD

Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis

Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity

Non-obese fatty liver disease is associated with lacunar infarct.

Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity

Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis ⬇️

Optimal timing for hepatitis C antiviral therapy in the peritransplant period?

PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-related Mortality in the United States

Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score.

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study

Recent Epidemiology of Nonalcoholic Fatty Liver Disease

Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.

Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease.

Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease

Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease

The Role of Cannabinoids in the Setting of Cirrhosis

The Role of Vitamin E in the Treatment of NAFLD

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD

The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States

Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017

Trends in Mortality in Hepatitis C Infection and Alcoholic Liver Disease based on Drug Overdose in the United States

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis

When to Initiate Weight Loss Medications in the NAFLD Population